After a run-in period ( 30 days ) , women with both migraine and TMD were enrolled into a four-arm , double-blind , placebo-controlled , factorial study testing the separate and joint effects of a migraine treatment ( propranolol 90 mg ) and a TMD treatment ( stabilization splint [ SS ] ) in four groups of patients .
